Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
08/2009
08/06/2009CA2712856A1 Use of eicosapentaenoic acid and/or docosahexaenoic acid in women with endometriosis
08/06/2009CA2710929A1 Imidazopyrazines as protein kinase inhibitors
08/05/2009EP2085395A1 Arylvinylazacycloalkane compounds and methods of preparation and use thereof
08/05/2009EP2085379A1 Arylsulfonamido-substituted hydroxamic acid derivatives
08/05/2009EP2085094A2 Application of aminopeptidases inhibitors and pharmaceutical preparations containing same
08/05/2009EP2085086A2 Method for treating congestive heart failure or diabetic nephropathy
08/05/2009EP2085085A1 The uses of the carboxy-amido-triazole compounds and salts thereof
08/05/2009EP2084155A1 Thiazole derivatives as kinase inhibitors
08/05/2009EP2084135A2 Pyrazole compounds
08/05/2009EP2084132A1 Positively charged water-soluble prodrugs of n-arylanthranilic acids with very fast skin penetration rate
08/05/2009EP2083922A1 VR1 RECEPTOR LIGANDS AND µ OPIOID RECEPTOR LIGANDS FOR THE TREATMENT OF PAIN
08/05/2009EP2083920A1 N-aryl-hydroxyalkylidene-carboxamide compounds and their use
08/05/2009EP1963270B1 Quaternary 3 -amido, n-methylpyridinium salts as anti -inflammatory agents
08/05/2009EP1931349A4 Use of sodium channel blockers for the management of musculoskeletal pain
08/05/2009EP1888541B1 Benzo(d)isoxazol-3-yl-amine compounds and their use as vanilloid receptor ligands
08/05/2009EP1781606B1 Azetidine derivatives as ccr-3 receptor antagonists
08/05/2009EP1531822B1 1-aryl-4-substituted piperazine derivatives for use as ccr1 antagonists for the treatment of inflammation and immune disorders
08/05/2009EP1509506B1 Pyridazine derivatives
08/05/2009EP1503778B1 Formulation of a mixture of free-b-ring flavonoids and flavans as a therapeutic agent
08/05/2009EP1501797B1 3-(substituted amino)-1h-indole-2-carboxylic acid ester and 3-(substituted amino)-benzo[b]thiophene-2-carboxylic acid ester derivatives as interleukin-4 gene expression inhibitors
08/05/2009EP1465880B1 5-sulphanyl-4h-1,2,4-triazole derivatives and their use to treat disorders associated with somatostatine
08/05/2009EP1461313B1 Human adam-10 inhibitors
08/05/2009EP1407004B1 Ex-vivo priming for generating cd40-ligand specific cytotoxic t lymphocytes to treat autoimmune and allergic disease
08/05/2009EP1383731B1 Biaryl compounds as serine protease inhibitors
08/05/2009EP1357111B1 2-pyridone derivatives having affinity for cannabinoid type 2 receptor
08/05/2009EP1341786B9 Substituted derivatives of aminofuran-2-yl-acetic acid and aminothien-2-yl-acetic acid and the use thereof for treating migraines and pain
08/05/2009CN101501070A Antigenic GM-CSF peptides and antibodies to GM-CSF
08/05/2009CN101501038A Fused [d]pyridazin-7-ones
08/05/2009CN101501023A Phenyl substituted heteroaryl-derivatives and use thereof as anti-tumor agents
08/05/2009CN101501018A Hydrogen sulfide derivatives of non-steroidal anti-inflammatory drugs
08/05/2009CN101500654A Compositions for the treatment of chronic degenerative inflammatory conditions
08/05/2009CN101500653A Treatment of gastrointestinal disorders with CGRP-antagonists
08/05/2009CN101500608A Preventive or remedy for inflammatory disease
08/05/2009CN101500563A Cycloalkanopyrolocarbazole derivatives and the use thereof as PARP, VEGFR2 and MLK3 inhibitors
08/05/2009CN101497615A Substituted purine, preparation and use in medicine
08/05/2009CN101496886A Effective powder for treating traumatic injury
08/05/2009CN101496859A External Chinese medicine paste for rheumatism and ostalgia
08/05/2009CN101496849A Chinese medicine preparation for treating atrophic arthritis
08/05/2009CN101496838A Chinese medicament preparation for treating hyperosteogeny and rheumatism and preparation method thereof
08/05/2009CN101496836A Chinese medicinal composition for treating common cold and preparation method thereof
08/05/2009CN101496835A Antipyretic medicament for treating common cold of children and preparation method thereof
08/05/2009CN101496833A Liquid external preparation for preparing total alkaloids in nux vomica
08/05/2009CN101496826A Medicament for stretching channel, activating collaterals, compensating deficiency and invigorating yang
08/05/2009CN101496802A Use of arylpiperazine derivatives in preparing medicament for treating ache
08/05/2009CN101496788A Aerosol of percutaneous medicament
08/05/2009CN100523187C Modified chimeric polyeptides with improved pharmacokinetic properties
08/05/2009CN100522967C Phosphorus-containing compounds & uses thereof
08/05/2009CN100522954C Kappa-opioid receptor agonist composed of 2-phenylbenzothiazoline derivative
08/05/2009CN100522945C Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and use thereof
08/05/2009CN100522944C Carboxylic acid derivative and thereof
08/05/2009CN100522943C Vitamin d analogues
08/05/2009CN100522249C Elogated and multiple spacers in activatible prodrugs
08/05/2009CN100522238C Pain-relieving and abdominal mass-eliminatnig bolus and its preparation
08/05/2009CN100522215C Traditional Chinese medicine composition for treating traumatic injury and bone fracture
08/05/2009CN100522208C Damp dispelling and pain relieving externally applied medicine and its preparing method
08/05/2009CN100522200C Pills for preventing osteoproliferation and preparing method thereof
08/05/2009CN100522177C Application of gastrodin in the medicine for treating rheumatoid arthritis
08/05/2009CN100522174C Crystalline isoxazole derivative and medical preparation thereof
08/05/2009CN100522168C Sustained releasing capsule of rotundine and its preparation method
08/05/2009CN100522164C Method of treating of demyelinating diseases or conditions
08/05/2009CN100522161C (Indol-3-yl)-heterocycle derivatives as agonists of the cannabinoid CB1 receptor
08/05/2009CN100522155C Use of retigabin for treating neuropathic pain
08/05/2009CN100522151C Compounds for treatment of inflammation, diabetes and related disorders
08/05/2009CN100522138C Preparation process and quality control technology of decoction of bupleurum root for regulating Shaoyang
08/05/2009CN100521957C Supine gynura root and producing method thereof
08/04/2009US7569592 Heteroaryl substituted pyrazole modulators of metabotropic glutamate receptor-5
08/04/2009US7569585 Drugs; analgesics; anesthetics; antiarrhythmia agents; antiinflammatory agents ; incontinence; gastrointestinal disorders; neurodegenerative disease
08/04/2009US7569569 Pyrrolo[2,3-d]pyrimidine compounds
08/04/2009US7569568 1-[5-(5-tert-Butyl-2-methoxy-phenylcarbamoyl)-2-methyl-phenyl]-1H-1,2,3-triazole-4-carboxylic acid (2-morpholin-4-yl-ethyl)-amide; inflammation, chronic inflammatory disease
08/04/2009US7569567 3-Heteroaryl-3,5-dihydro-4-oxo-4H-pyridazino[4,5-B]indole-1-carboxamide derivatives, their preparation and therapeutic use
08/04/2009US7569561 For treating carcinoma chosen from cervical, breast, colon, head and neck, lung, pancreas, prostate, sarcomas, leukaemias, lymphomas, melanomas and gliomas
08/04/2009US7569549 Crystallizing in water-miscible solvent, water, and mineral/organic acid
08/04/2009US7569387 Specifically binds an MK61 polypeptide produced by immunizing an animal
08/04/2009US7569364 Anti-NGF antibodies and methods using same
08/04/2009US7569218 Compositions for and methods of using herpes simplex virus glycoprotein D to suppress immune responses
08/04/2009CA2496476C Therapeutic use
08/04/2009CA2433785C Pharmaceutical compositions which inhibit vascular proliferation and method of use thereof
08/04/2009CA2424566C Dental care compositions
08/04/2009CA2406057C Methods and compositions for modulating alpha adrenergic receptor activity
07/2009
07/30/2009WO2009094168A1 Cxcr3 antagonists
07/30/2009WO2009094157A1 Dihydro- 1h- pyrrolo [1,2-a] indol-1-yl carboxylic derivatives which act as s1p1 agonists
07/30/2009WO2009093981A1 Triazine compounds as kinase inhibitors
07/30/2009WO2009093755A1 Agent for increasing blood adiponectin quantity
07/30/2009WO2009093013A1 Fused thiophene derivatives as mek inhibitors
07/30/2009WO2009093009A1 Fused tricyclic thiophene derivatives as mek inhibitors
07/30/2009WO2009092912A1 Method for the preparation of morphine compounds
07/30/2009WO2009092284A1 Benzocycloheptene derivatives, preparing processes and pharmaceutical uses thereof
07/30/2009WO2009067243A3 Modulation of cd40 expression
07/30/2009WO2008109352A8 Nucleic acid compounds for inhibiting akt gene expression and uses thereof
07/30/2009US20090192292 Murine zcytor17 ligand polypeptides and polynucleotides
07/30/2009US20090192230 Propofol-containing fat emulsion preparation
07/30/2009US20090192206 Mercaptoimidazoles as ccr2 receptor antagonists
07/30/2009US20090192183 Oxymorphone Controlled Release Formulations
07/30/2009US20090192171 5-Lipoxygenase-Activating Protein (FLAP) Inhibitors
07/30/2009US20090192129 Bicyclic pyrrole derivatives
07/30/2009US20090192105 RNA INTERFERENCE MEDIATED INHIBITION OF INTERCELLULAR ADHESION MOLECULE (ICAM) GENE EXPRESSION USING SHORT INTERFERING NUCELIC ACID (siNA)
07/30/2009US20090192094 Treatment of diseases using ice inhibitors
07/30/2009US20090192088 Vascular Endothelial Growth Factor 2
07/30/2009US20090191287 Mitigation of Inflammation-Related Injuries
07/30/2009US20090191267 Oral Compositions Containing a Salivation Inducing Agent
1 ... 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 ... 1272